Summary
As governments across Europe have issued non-pharmaceutical interventions (NPIs) such as social distancing and school closing, the mobility patterns in these countries have changed. It is likely different countries and populations respond differently to the same NPIs and that these differences are reflected in the epidemic development. Here, we model the impact of the changes in mobility patterns in 11 European countries by estimating the effect of these on the basic reproductive number, R0, in a Bayesian framework. By modelling changes in R0 with real-life mobility data, the true effects of responses to NPIs across different countries can be modelled more accurately. We assume the impact of each mobility change has the same relative impact across all countries and across time. We utilize mobility data from Google mobility reports using five different categories: retail and recreation, grocery and pharmacy, transit stations, workplace and residential. The changes in mobility have a large overlap with the introduction of governmental NPIs, highlighting the importance of government action for population behavioural change. The importance of each mobility category for predicting changes in R0 is estimated through the model. The grocery and pharmacy parameter is estimated to account for above 90 % of the reduction in R0 with a very narrow confidence interval. The model predicts that immediately after the NPIs, R0 rose in several countries as activities in grocery and pharmacy increased, but then it dropped sharply as those activities decreased. We do see worrying patterns in northern Europe as predicted values of R0 are still clearly above 1.0 there, in particular in Sweden with an R0 of 2.27.
SUGGESTED CITATION Patrick Bryant and Arne Elofsson. Estimating the impact of mobility patterns on COVID-19 in 11 european countries. Stockholm University and Science for Life Laboratory (2020).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Swedish Research Council for Natural Science grant No. VR-2016-06301 to AE.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
patrick.bryant{at}scilifelab.se | arne{at}bioinfo.se
Data Availability
All code is freely available at https://github.com/patrickbryant1/COVID19.github.io/ under the GPLv3 license. Data and future predictions will be made available at https://covid19.bioinfo.se/